Let‐7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Top Cited Papers
Open Access
- 28 August 2019
- journal article
- review article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 8 (1), 24
- https://doi.org/10.1186/s40169-019-0240-y
Abstract
Abnormal regulation and expression of microRNAs (miRNAs) has been documented in various diseases including cancer. The miRNA let‐7 (MIRLET7) family controls developmental timing and differentiation. Let‐7 loss contributes to carcinogenesis via an increase in its target oncogenes and stemness factors. Let‐7 targets include genes regulating the cell cycle, cell signaling, and maintenance of differentiation. It is categorized as a tumor suppressor because it reduces cancer aggressiveness, chemoresistance, and radioresistance. However, in rare situations let‐7 acts as an oncogene, increasing cancer migration, invasion, chemoresistance, and expression of genes associated with progression and metastasis. Here, we review let‐7 function as tumor suppressor and oncogene, considering let‐7 as a potential diagnostic and prognostic marker, and a therapeutic target for cancer treatment. We explain the complex regulation and function of different let‐7 family members, pointing to abnormal processes involved in carcinogenesis. Let‐7 is a promising option to complement conventional cancer therapy, but requires a tumor specific delivery method to avoid toxicity. While let‐7 therapy is not yet established, we make the case that assessing its tumor presence is crucial when choosing therapy. Clinical data demonstrate that let‐7 can be used as a biomarker for rational precision medicine decisions, resulting in improved patient survival.Keywords
Funding Information
- Loma Linda University, Division of Anatomy
- Loma Linda University
This publication has 140 references indexed in Scilit:
- OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathwayCell Death & Disease, 2013
- Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct MechanismsCell, 2011
- Molecular Basis for Interaction of let-7 MicroRNAs with Lin28Cell, 2011
- The Lin28/let-7 Axis Regulates Glucose MetabolismCell, 2011
- Let‐7 modulates acquired resistance of ovarian cancer to Taxanes via IMP‐1‐mediated stabilization of multidrug resistance 1International Journal of Cancer, 2011
- Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancerInternational Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Loss of Bright/ARID3a Function Promotes Developmental PlasticityThe International Journal of Cell Cloning, 2010
- Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinomaJournal of Hepatology, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009